Cormorant Asset Management, LP Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$2.5T
Holdings
62
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (62 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 1,782,392 | $229.7B | 9.17% | Call |
| 2 | RETAEURREATA PHARMACEUTICALS INC | 1,066,400 | $218.0B | 8.70% | Call |
| 3 | —TURNING POINT THERAPEUTICS I | 3,396,650 | $211.6B | 8.44% | |
| 4 | CCXIEURCHEMOCENTRYX INC | 3,150,000 | $124.6B | 4.97% | Call |
| 5 | —PRINCIPIA BIOPHARMA INC | 1,990,922 | $109.1B | 4.35% | |
| 6 | —CONSTELLATION PHARMCETICLS I | 2,300,000 | $108.4B | 4.32% | |
| 7 | ASNDASCENDIS PHARMA A S | 650,000 | $90.4B | 3.61% | Call |
| 8 | BBIOBRIDGEBIO PHARMA INC | 2,512,865 | $88.1B | 3.51% | |
| 9 | APLSAPELLIS PHARMACEUTICALS INC | 2,700,000 | $82.7B | 3.30% | |
| 10 | —BIOHAVEN PHARMACTL HLDG CO L | 1,500,000 | $81.7B | 3.26% | Call |
| 11 | AXSMAXSOME THERAPEUTICS INC | 600,000 | $62.0B | 2.47% | |
| 12 | CRSPCRISPR THERAPEUTICS AG | 1,000,000 | $60.9B | 2.43% | |
| 13 | NXTCNEXTCURE INC | 1,000,000 | $56.3B | 2.25% | |
| 14 | —MYOKARDIA INC | 700,000 | $51.0B | 2.04% | |
| 15 | STOKSTOKE THERAPEUTICS INC | 1,788,643 | $50.7B | 2.02% | |
| 16 | YMABUSDY-MABS THERAPEUTICS INC | 1,602,376 | $50.1B | 2.00% | |
| 17 | XBISPDR SERIES TRUST | 500,000 | $47.6B | 1.90% | Put |
| 18 | RCKTROCKET PHARMACEUTICALS INC | 1,837,269 | $41.8B | 1.67% | |
| 19 | —VIELA BIO INC | 1,497,500 | $40.7B | 1.62% | |
| 20 | 1T7TRICIDA INC | 927,975 | $35.0B | 1.40% | |
| 21 | AXNX*AXONICS MODULATION TECH INC | 1,222,671 | $33.9B | 1.35% | |
| 22 | —QUOTIENT LTD | 3,500,000 | $33.3B | 1.33% | |
| 23 | SRPTSAREPTA THERAPEUTICS INC | 250,000 | $32.3B | 1.29% | |
| 24 | —ZYMEWORKS INC | 700,000 | $31.8B | 1.27% | |
| 25 | —MYOVANT SCIENCES LTD | 2,000,000 | $31.0B | 1.24% | |
| 26 | CABACABALETTA BIO INC | 2,119,132 | $29.6B | 1.18% | |
| 27 | QUREUNIQURE NV | 400,000 | $28.7B | 1.14% | |
| 28 | ALLKGUSDALLAKOS INC | 300,000 | $28.6B | 1.14% | |
| 29 | —EIDOS THERAPEUTICS INC | 495,692 | $28.4B | 1.14% | |
| 30 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 450,000 | $28.0B | 1.12% | |
| 31 | AMRNAMARIN CORP PLC | 1,300,000 | $27.9B | 1.11% | |
| 32 | 2L9BLUEPRINT MEDICINES CORP | 345,000 | $27.6B | 1.10% | |
| 33 | —IMMUNOVANT INC | 1,080,000 | $26.5B | 1.06% | |
| 34 | OMEROMEROS CORP | 1,525,000 | $21.5B | 0.86% | |
| 35 | GLPGGALAPAGOS NV | 100,000 | $20.9B | 0.83% | |
| 36 | —SATSUMA PHARMACEUTICALS INC | 858,382 | $16.9B | 0.67% | |
| 37 | AKROAKERO THERAPEUTICS INC | 740,621 | $16.4B | 0.66% | |
| 38 | ARGXARGENX SE | 100,000 | $16.1B | 0.64% | |
| 39 | TWSTTWIST BIOSCIENCE CORP | 687,149 | $14.4B | 0.58% | |
| 40 | MRUSMERUS N V | 1,000,000 | $14.1B | 0.56% | |
| 41 | —RA PHARMACEUTICALS INC | 295,600 | $13.9B | 0.55% | |
| 42 | KURAKURA ONCOLOGY INC | 1,000,000 | $13.8B | 0.55% | |
| 43 | SRNESORRENTO THERAPEUTICS INC | 4,000,000 | $13.5B | 0.54% | |
| 44 | INSPINSPIRE MED SYS INC | 172,300 | $12.8B | 0.51% | |
| 45 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 833,400 | $12.4B | 0.50% | |
| 46 | ZLABZAI LAB LTD | 277,161 | $11.5B | 0.46% | |
| 47 | —HARPOON THERAPEUTICS INC | 649,994 | $9.6B | 0.38% | |
| 48 | ARNAEURARENA PHARMACEUTICALS INC | 172,300 | $7.8B | 0.31% | |
| 49 | DTILPRECISION BIOSCIENCES INC | 467,516 | $6.5B | 0.26% | |
| 50 | —AVROBIO INC | 317,579 | $6.4B | 0.26% | |
| 51 | AUTLAUTOLUS THERAPEUTICS PLC | 479,988 | $6.3B | 0.25% | |
| 52 | 1K0IGM BIOSCIENCES INC | 156,400 | $6.0B | 0.24% | |
| 53 | ANABANAPTYSBIO INC | 365,000 | $5.9B | 0.24% | |
| 54 | BCELATRECA INC | 326,141 | $5.0B | 0.20% | |
| 55 | ORTXUSDORCHARD THERAPEUTICS PLC | 350,203 | $4.8B | 0.19% | |
| 56 | GOSSGOSSAMER BIO INC | 300,000 | $4.7B | 0.19% | |
| 57 | NERVGBPMINERVA NEUROSCIENCES INC | 607,903 | $4.3B | 0.17% | |
| 58 | NKTREURNEKTAR THERAPEUTICS | 200,000 | $4.3B | 0.17% | |
| 59 | NBIXNEUROCRINE BIOSCIENCES INC | 39,300 | $4.2B | 0.17% | |
| 60 | ASNSUSDX4 PHARMACEUTICALS INC | 252,747 | $2.7B | 0.11% | |
| 61 | TBPHTHERAVANCE BIOPHARMA INC | 50,000 | $1.3B | 0.05% | |
| 62 | —OUTLOOK THERAPEUTICS INC | 416,666 | $27.0M | 0.00% |